Use of Intravenous Immunoglobulin Therapy in a paediatric rheumatology service
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Use of Intravenous Immunoglobulin Therapy in a paediatric rheumatology service ; volume:6 ; number:1 ; day:15 ; month:9 ; year:2008 ; pages:1 ; date:9.2008
Pediatric rheumatology ; 6, Heft 1 (15.9.2008), 1, 9.2008
- Urheber
-
Saladi, SM
Cleary, AG
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1546-0096-6-S1-P48
- URN
-
urn:nbn:de:101:1-2019111722250654999373
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Saladi, SM
- Cleary, AG
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
Rheumatology and therapy
Clinical false positives resulting from recent intravenous immunoglobulin therapy: case report
Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
Proceedings of the 29th European Paediatric Rheumatology Congress
Phenytoin-Induced Toxic Epidermal Necrolysis with Immediate Remission Post Intravenous Immunoglobulin Therapy
Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and intravenous immunoglobulin (IVIG): comprehensive open-label trial in ten children
Educational initiatives and training for paediatric rheumatology in Europe
Revising the WHO Essential Medicines List for paediatric rheumatology
Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
Rheumatology and therapy
Clinical false positives resulting from recent intravenous immunoglobulin therapy: case report
Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
Proceedings of the 29th European Paediatric Rheumatology Congress
Phenytoin-Induced Toxic Epidermal Necrolysis with Immediate Remission Post Intravenous Immunoglobulin Therapy
Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and intravenous immunoglobulin (IVIG): comprehensive open-label trial in ten children
Educational initiatives and training for paediatric rheumatology in Europe
Revising the WHO Essential Medicines List for paediatric rheumatology
Intravenous immunoglobulin G therapy for neonatal hyperbilirubinemia
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
Rheumatology and therapy
Clinical false positives resulting from recent intravenous immunoglobulin therapy: case report
Intravenous immunoglobulin fails to improve ARDS in patients undergoing ECMO therapy
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
Proceedings of the 29th European Paediatric Rheumatology Congress
Phenytoin-Induced Toxic Epidermal Necrolysis with Immediate Remission Post Intravenous Immunoglobulin Therapy
Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and intravenous immunoglobulin (IVIG): comprehensive open-label trial in ten children
Educational initiatives and training for paediatric rheumatology in Europe